Norovirus cases in England's hospitals hit highest level this winter
New data from NHS England shows an average of 898 hospital beds were filled each day last week by patients with diarrhoea and vomiting or norovirus-like symptoms, up 15% from 784 the previous week.
The figure had previously peaked at 837 in early December.
Norovirus levels are higher than at this point 12 months ago, when an average of 688 beds were filled with patients with symptoms, and also two years ago (395 patients).
Meanwhile, flu levels in hospitals in England have fallen for the third week in a row.
An average of 3,019 flu patients were in beds each day last week, including 148 in critical care.
This is down 21% from 3,833 the previous week, when 176 were in critical care.
The total is still higher than this point last winter (2,226) and also this stage two years ago (1,291).
The figures have been published in the latest weekly snapshot of the performance of hospitals in England, and show that Covid continues to fall.
NHS England said pressure on hospital capacity remained high last week with an average of 96% adult beds occupied and a total of 97,567 patients in hospital each day.
There was also an average of 13,426 patients in hospital each day despite being medically fit for discharge, taking up more than one in seven available beds.
Professor Julian Redhead, national clinical director for urgent and emergency care, said: 'It is welcome news that the number of patients in hospital with Covid and flu continued to fall last week, however the worrying surge in norovirus cases – now at their highest level so far this winter – means there is no let up for NHS staff.
'Hospitals remain close to capacity, with almost a fifth of beds filled due to seasonal viruses and delayed discharges to settings like social and community care.
'The public can help us out by continuing to only call 999 or visit A&E in a life-threatening emergency or using NHS 111 for other conditions.
'With the higher than usual levels of norovirus, it is important to remember to wash your hands frequently with soap and water, and avoid close contact with others if you have any symptoms.
'If you haven't had your Covid jab yet and are eligible, make sure you don't miss out and get to a walk-in service today or tomorrow.'
Health and Social Care Secretary Wes Streeting said: 'Hospitals up and down the country are continuing to grapple with challenging conditions, and I know NHS staff are feeling significant pressure as they work hard for patients.
'The broken NHS system we inherited has meant too many people have suffered unacceptable standards of care this winter, but we are steadfast in our commitment to turn that around as we deliver the reforms required through our Plan for Change.
'Today we are publishing the NHS mandate which sets out that improving A&E and ambulance waiting times should be among the top priorities for trusts as we set the direction for the health service over the coming year.'
Elsewhere, the UK Health Security Agency (UKHSA) said cases of tuberculosis (TB) in England increased by 13% in 2024, from 4,850 in 2023 to 5,480 in 2024.
Some 81.5% of all TB cases in 2024 were in people born outside the UK but there was an increase in both UK born and non-UK born populations, it said.
TB is associated with deprivation and is more common in large urban areas.
The largest increases in TB were recorded in London and the West Midlands, the UKHSA said.
Dr Esther Robinson, head of the TB unit at the UKHSA, said: 'TB remains a serious public health issue in England.
'The infection is preventable and curable.
'If you have moved to England from a country where TB is more common, please be aware of the symptoms of TB so you can get promptly tested and treated through your GP surgery.
'Not every persistent cough, along with a fever, is caused by flu or Covid-19.
'A cough that usually has mucus and lasts longer than three weeks can be caused by a range of other issues, including TB.
'Please speak to your GP if you think you could be at risk.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NBC News
24 minutes ago
- NBC News
RFK Jr. cuts $500 million in mRNA vaccine contracts, dealing major blow to promising area of research
The Trump administration is terminating 22 contracts focused on developing mRNA vaccines and winding down additional federal investments in mRNA technology, Health and Human Services Secretary Robert F. Kennedy Jr. announced Tuesday. Many scientists and infectious disease experts swiftly denounced the move as a broadside on an area of research seen as particularly promising after its use in rapidly developing Covid vaccines. The projects that are being axed were funded by the Biomedical Advanced Research and Development Authority (BARDA), a Department of Health and Human Services program that works with the pharmaceutical industry to develop vaccines and other countermeasures for public health emergencies. 'This isn't just about vaccines,' Rick Bright, who directed BARDA from 2016 to 2020, said in a text message. 'It's about whether we'll be ready when the next crisis hits. Cutting mRNA development now puts every American at greater risk.' 'The Covid pandemic showed us what's possible when science moves fast,' he added. 'Dismantling that momentum now is like disbanding the fire department because the fire's out.' Kennedy said Tuesday that the terminated contracts were worth nearly $500 million. Among them is an award to the University of Texas Medical Branch and the biotechnology company Moderna to develop an mRNA-based vaccine for H5N1, the strain of bird flu that has infected dozens of people in the United States. "After reviewing the science and consulting top experts at NIH and FDA, HHS has determined that mRNA technology poses more risks and benefits for these respiratory viruses," Kennedy said in a video announcement on X. "Let me be absolutely clear, HHS supports safe, effective vaccines for every American who wants them," he added. "That's why we're moving beyond the limitations of mRNA for respiratory viruses and investing in better solutions." The move adds to mounting evidence that Kennedy, a high-profile figure in the anti-vaccine movement who softened his rhetoric after the presidential election and in confirmation hearings, is pursuing an aggressive anti-vaccine agenda that includes gutting a crucial vaccine advisory committee and cutting $2 billion from a program that supports vaccines for vulnerable children. Kennedy has referred to Covid shots as the 'deadliest vaccine ever made,' a claim contradicted by reams of studies that have found them to be safe. The Centers for Disease Control and Prevention estimates the vaccines saved more than 200,000 lives in the United States and prevented more than 1.5 million hospitalizations in the first 10 months they were available. Many pharmaceutical companies have prioritized mRNA research because the platform can easily be updated to target new viruses or variants, and scientists see it as an important tool to prepare for future pandemics. But mRNA technology has become a primary target for anti-vaccine activists who have argued — despite ongoing and sizable research — that it represents a massive safety threat. Children's Health Defense, the anti-vaccine group founded by Kennedy, applauded defunding mRNA vaccine projects under BARDA on Tuesday. "While we believe that the mRNA shots on the market are unsafe and should be off the market, this is a welcome step in the right direction. The pandemic preparedness industry as it exists today is a threat to human welfare," CEO Mary Holland said in a statement on X. In his announcement Tuesday, Kennedy suggested that mRNA vaccines fail to sufficiently protect against Covid and flu, that they can be rendered ineffective by a single mutation and that they can even prolong pandemics. But infectious disease and vaccine experts said he grossly mischaracterizes the science. "That's exactly why mRNA is so valuable: It's the only platform where you can actually update the vaccine really quickly," said Dr. Jake Scott, an infectious disease specialist at Stanford Medicine. Terminating mRNA contracts under BARDA is "a very misguided, irresponsible and I would say reckless move," Scott said. "It really does reveal a fundamental misunderstanding of how vaccines work and how a vaccine against a respiratory virus in particular should be expected to work." Kennedy said Tuesday that the BARDA funding would be shifted 'toward safer, broader vaccine platforms that remain effective even as viruses mutate," such as whole-virus vaccines, which use weakened or deactivated versions of viruses to trigger immune responses.
Yahoo
an hour ago
- Yahoo
New COVID variant 'Stratus' is spreading in the U.S. and worldwide: What are the symptoms?
A new COVID variant is climbing the ranks in the U.S., becoming the third-most common strain of the summer. Variant XFG, colloquially known as "Stratus," was first detected in Southeast Asia in January but accounted for less than about 0% of cases in the United States until May. By late June, it was estimated to account for up to 14%, according to the Centers for Disease Control and Prevention (CDC). The World Health Organization (WHO) added XFG to its watchlist but evaluated the additional public health risk posed by the variant as "low" at the global level in a late June report, in which it also advised that currently approved COVID-19 vaccines are "expected to remain effective to this variant against symptomatic and severe disease." Here's what we know about XFG. What is COVID variant XFG? XFG is a combination of COVID-19 variants F.7 and LP.8.1.2, the latter of which is currently the second most prominent strain in the U.S. The variant's mutations may enhance XFG's ability to evade immune responses, but its binding behavior shows that it is less likely to be highly contagious than other dominant variants, Subhash Verma, microbiology and immunology professor at the University of Nevada, Reno, told USA TODAY. "There is currently no clear evidence that XFG causes more severe disease or significantly different symptoms than earlier Omicron variants," said Verma. "Importantly, there are no immediate public health concerns associated with this variant." How common is XFG? While XFG has been growing and spreading worldwide, it has yet to become the predominant source of infection in the United States. The CDC has moved to using longer timeframes for COVID tracking due to low reporting from states. According to the latest data for the two-week period ending June 21, XFG accounted for 14% of U.S. cases, making it the third most-prevalent strain after NB.1.8.1 (43%) and LP.8.1 (31%). The prominence of XFG in the United States significantly increased in the weeks leading up to the last report, accounting for 0% of cases through March before reaching 2% in April, 6% in late May, 11% in early June and 14% in late June. WHO tracked an uptick in XFG worldwide in June as well, with the June report including data from 38 countries showing that XFG accounted for only 7.4% of positive tests in the first week of May but 22.7% by the last. USA TODAY has reached out to the CDC for more information about the spread of COVID variants in July and August. What are the symptoms of XFG? There is no evidence that XFG causes any distinct symptoms from other variants, said Verma. However, hoarseness has been anecdotally associated with the strain, according to social media posts and news reports. The CDC outlines the following as common COVID-19 symptoms: Fever or chills Cough Shortness of breath or difficulty breathing Sore throat Congestion or a runny nose New loss of taste or smell Fatigue Muscle or body aches Headache Nausea or vomiting The CDC advises seeking medical care if you experience any of the following symptoms: Trouble breathing Persistent pain or pressure in the chest New confusion Inability to wake or stay awake Depending on skin tone, lips, nail beds and skin may appear pale, gray, or blue This article originally appeared on USA TODAY: New COVID variant 'Stratus' spreading in US: symptoms, what to know Solve the daily Crossword
Epoch Times
an hour ago
- Epoch Times
HHS Cancels 22 MRNA Vaccine Development Contracts
Health and Human Services Secretary Robert F. Kennedy Jr. announced on Aug. 5 that 22 mRNA vaccine development contracts are being canceled and redirected 'because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu.' The mRNA development activities are spearheaded by the Biomedical Advanced Research and Development Authority (BARDA), which is managed by Global Health Investment Corporation (GHIC).
